Breaking News

Janssen Forms New Group

Will target new medicines to address unmet health needs

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Janssen, the pharmaceutical companies of Johnson & Johnson, has formed Janssen Global Public Health (Janssen GPH), a new group aimed at unifying Janssen’s R&D to deliver new medicines to address unmet public health needs. Janssen GPH will partner with other organizations within the company to advance its global public health goals.  Adrian Thomas, M.D., vice president of Global Market Access, Global Commercial Strategy Operations, and Global Public Health, and Wim Parys, M.D., vic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters